On (b)(6) 2017 a patient (pt) from (b)(6) called to report while wearing the acuvue oasys for astigmatism brand contact lenses he/she experienced redness, tearing, swelling and pain that began on (b)(6) 2017.The pt was given trial lenses on (b)(6) 2017, but did not wear the lenses every day.Pt could only wear the lenses for a few hours.Pt went to the eye hospital and was diagnosed with a bacterial infection in the right eye.Pt was prescribed gentamycin eye drops every hour for three days.Pt returned for a follow-up visit the following day.Pt reported a follow-up visit scheduled for (b)(6) 2017 for ¿discharge¿.Pt reports being told by the optical that the lenses could be worn thirty times.Pt did not sleep in the lenses.Pt discarded the suspect lens and was unable to provide the name of the solution used to disinfect and store the lenses.On (b)(6) 2017 a call was placed to the optical and spoke with the contactologist who reported the pt came in with ¿issues¿ with an unknown brand of lenses.The contactologist reported the pt was given trial lenses for the oasys for astigmatism lenses.The lot number of the suspect lens was unknown.The solution the pt was using at the time of the reported as arlyte premium solution.On (b)(6) 2018 a call was placed to the pts treating eye clinic for additional medical information.A representative reported the pt would have to present to the clinic and get the records.No medical information was provided.On (b)(6) 2018 an email was received from pt with the medical summary from the eye care provider (ecp): - medical summary dated (b)(6) 2017: "pt developed a right eye corneal abscess caused by contact lens trauma on (b)(6) 2017.After treatment of topical antibiotics, the pt was discharged, cured and without further consequence on (b)(6) 2017." no additional medical information has been received.The lot number is unknown and the suspect lens was discarded.If additional information is received it will be reported within 30 days of receipt.Serious reportable event trends are reviewed quarterly in franchise management review meetings.
|